Atlas Trials

A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancer

Clinical trial NCT03143270 · COMPLETED

Trial details

NCT number
NCT03143270
Sponsor
Memorial Sloan Kettering Cancer Center
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Liver Cancer
Start date
2017-04-28
Primary completion
2026-08-03
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.